Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Wall Street Opens Lower on Omicron Fears; Dow Down 260 Points

Stock MarketsNov 30, 2021 16:40
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters

By Geoffrey Smith 

Investing.com -- U.S. stock markets opened lower on Tuesday but were well off the lows seen by futures in the overnight session as uncertainty continued to swirl around the implications of a new dominant Covid-19 strain for the global economy and financial markets. 

By 9:45 AM ET (1445 GMT), the Dow Jones Industrial Average was down 262 points, or 0.8%, at 34,874 points. The S&P 500 was down 0.6% and the Nasdaq Composite was down 0.2%. 

The Dow was weighed on, and the Nasdaq supported, by the rapid change in expectations for U.S. interest rates that the news flow around Omicron has caused. Short-term interest rate futures now expect the first interest rate increase from the Federal Reserve no earlier than September, rather than in June as was the case last Thursday, before the Omicron news was discounted.

Futures had sold off heavily overnight after the Financial Times published an interview with Moderna (NASDAQ:MRNA) CEO Stephane Bancel, in which he warned of a "material drop" in vaccine effectiveness against the so-called Omicron strain.  Regeneron (NASDAQ:REGN) followed up by saying that preliminary results showed that its experimental antiviral pill was also less effective against Omicron than against other variants of the disease.

However, Oxford University in England, which was behind the vaccine more commonly known as AstraZeneca (NASDAQ:AZN)'s, said there was no evidence yet that vaccines will be less effective. In addition, case numbers in South Africa, where the strain was first detected, have fallen for the last two days. 

Moderna stock sold off 7.5% after Bancel's comments, while BioNTech stock fell 7.0%. Regeneron stock was more resilient, however, falling only 0.7%. BioNTech's partner Pfizer (NYSE:PFE) saw its stock even rise 1.7%. Adagio Therapeutics (NASDAQ:ADGI), which on Monday said that its experimental antibody product ADG20 performed well in early trials against the Omicron strain, rose another 50%. The stock has almost quadrupled in the last four days. 

Another biotech performing well was Cumberland Pharmaceuticals (NASDAQ:CPIX), which doubled after receiving Food and Drug Administration approval for its intravenous ibuprofen solution Caldolor.

Broadly speaking, the news flow hit travel, hospitality and banking stocks hardest, without generating much in the way of gains for stay-at-home stocks such as Zoom Video - which fell 0.6% - or Amazon (NASDAQ:AMZN), which eked out only a 0.6% gain. Roblox stock continued its recent impressive run, however, rising 5.4%. Business software provider Intuit (NASDAQ:INTU) saw its stock fall 2.3% after pricing a secondary offering at a modest discount to the market.

Elsewhere, the slump in oil prices continued, but with a relatively muted impact on oil and gas stocks. Exxon Mobil (NYSE:XOM) stock fell 1.4% and Occidental (NYSE:OXY) stock fell 2.0%, but Chevron (NYSE:CVX) stock limited losses to 0.3% even as U.S. crude futures slumped another 2.8% to their lowest since early September.

 

Wall Street Opens Lower on Omicron Fears; Dow Down 260 Points
 

Related Articles

Helbiz Expands Segway Partnership
Helbiz Expands Segway Partnership By Investing.com - Jan 21, 2022

By Sam Boughedda Investing.com — Micro-mobility company Helbiz Inc (NASDAQ:HLBZ) announced Friday that it has expanded its partnership with Segway, a personal transportation...

Nasdaq Moves Off Lows After Dipping Below 14,000
Nasdaq Moves Off Lows After Dipping Below 14,000 By Investing.com - Jan 21, 2022

By Yasin Ebrahim Investing.com – The Nasdaq moved off session lows Friday after falling below the key 14,000 level, as a Netflix-led rout in tech eased and dip-buying in...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email